Login to Your Account

Arix planning London IPO, seeks $125M to invest in 'best science'

By Nuala Moran
Staff Writer

Thursday, February 2, 2017

LONDON – Arix Bioscience Ltd. is to float on the main market of the London Stock Exchange, raising up to £100 million (US$125.6 million) to form and fund drug discovery and development companies from startup to maturity.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription